baber/WOPTO huggingface dataset:
Patent FI-844426-A0 (FI)
Inventor: JONCKERS KEES
IPC: C07C273/04
Filed: 1984-11-12
Abstract: Process for preparing urea in which,
 in a synthesis zone, at a pressure of 125-350 bar and at the temperature belonging thereto, a urea synthesis solution containing carbamate and free ammonia is formed from carbon dioxide and an excess of ammonia,
 in a first decomposition step, at synthesis pressure or lower, a part of the carbamate is decomposed by supply of heat and the gas phase obtained in this process is condensed in a first condensition zone,
 in a second decomposition step, at a pressure of 4-40 bar, a further part of the carbamate still present is decomposed by supply of heat and the gas phase formed is separated off,
 in a further step, the remaining carbamate is removed in the form of a gas mixture containing ammonia and carbon dioxide, and this gas mixture is processed to form a solution of ammonia and carbon dioxide in water,
 and the remaining urea-containing solution is processed to form a concentrated urea solution. 
<??>The urea solution to be concentrated is introduced into the tubes of a shell and tube heat exchanger, the gas mixture from the second decomposition step is led into the shell side of heat exchanger at the end opposite the place where the urea solution to be concentrated is fed, the solution of ammonia and carbon dioxide in water is fed to the said shell side at a place located between the inlet for the gas mixture and the inlet for the urea solution to be concentrated, and the condensate is discharged from the shell side at the end where the urea solution is led into the tubes.
Patent FI-852667-A0 (FI)
Inventor: SCANTLEBURY TODD VAN NESS
IPC: A61K6/00
Filed: 1985-07-05
Abstract: An article for treatment of periodontal disease is disclosed. In use, the gingival tissue is separated from a tooth surface in an area where periodontal disease is present. A biocompatible, porous material (22) capable of supporting ingrowth of gingival connective tissue and preventing apical migration of gingival epithelium is placed in a laminar relationship to a portion of the perimeter of the tooth surface. The gingival tissue is repositioned around the tooth and in contact with the porous material, with the porous material positioned between the gingival tissue and the tooth. One preferred article comprises a first portion (22) which is capable of supporting ingrowth of gingival connective tissue and preventing apical migration of gingival epithelium and a second portion (24) which is impermeable to oral tissues.
Patent FI-853681-A0 (FI)
Inventor: GREISER WOLFGANG
IPC: D04H1/46
Filed: 1985-09-25
Abstract: A multilayered fabric which when used as support material for built-up roofing and sealing membranes shows not only good fire properties but also improved mechanical properties is obtained by needling together two preconsolidated fibre webs, one of which consists of synthetic fibres and the other of mineral fibres. The needling produces a strong positive bond between the two webs, which prevents the parting of the two layers under extreme thermomechanical conditions.
Patent FI-861692-A0 (FI)
Inventor: GRAUER LANA
IPC: C07K16/30
Filed: 1986-04-22
Abstract: A novel tumor-associated antigen expressed by colon carcinoma is disclosed. The antigen, characterised by monoclonal antibody CCK061, is a glycoprotein having a molecular weight in the range of about 820,000 to about 960,000 and isoelectric points within the ranges of about 4.5 to about 5.0 and about 5.1 to about 5.9. Antibodies directed against the antigen, methods for their production and diagnostic and therapeutic uses therefor are provided.
Patent FI-861903-A0 (FI)
Inventor: BATT DOUGLAS GUY
IPC: C07C65/24
Filed: 1986-05-07
Abstract: 2-Substituted-1-naphthols are 5-lipoxygenase inhibitors which make them useful in the treatment of inflammation, obstructive lung diseases and/or psoriasis. Useful 2-substituent groups are alkyls, alkenyls, alkynyls, cycloalkyls, cycloalkenyls, the groups CH2-C 3BOND C-(CH2)mR5 and CH=CH-(CH2)nR5 (where m is 1-4, n is 0-3 and R5 includes phenyl, COOR9, where R9 is H or alkyl of 1-4 carbons, AR6 (where A is a methylene chain and R6 is a variety of groups including Cl, Br, I, CHO, CN, COOR9, NH2, SC(NH)NH2, phenyl, P(O)(OR9)2, etc.), and CHR7R21 (where R7 is a variety of aromatic and heterocyclic groups and R21 is H, optionally substituted phenyl and a variety of heterocyclic groups).
Patent FI-872469-A0 (FI)
Inventor: MILLIMAN KEITH L
IPC: F41B11/62
Filed: 1987-06-02
Abstract: A gun is provided with a pivoting barrel (25) and a cocking and retaining lever (61) which cocks the hammer (34) and retains the barrel in the firing position. When the lever moves to the unlocking position, the barrel is released and the hammer is cocked. When the barrel is loaded, the barrel is pivoted back to the firing position and the lever is moved to the locking position to retain the barrel.
Patent FI-875090-A0 (FI)
Inventor: GOSSER LAWRENCE WAYNE
IPC: C01B15/029
Filed: 1987-11-18
Abstract: A process for making hydrogen peroxide from hydrogen and oxygen employing an aqueous reaction medium containing a bromide promoter is disclosed.
Patent FI-881417-A0 (FI)
Inventor: BENDER ARNE
IPC: A01F29/04
Filed: 1988-03-24
Abstract: A device for chopping straw of the type which comprises a rotor arranged in an apparatus housing, said rotor having a plurality of knife arms detachably attached thereto and which when rotated pass between a number of counter-knives attached to a knife beam. The knife arms and counter-knives comprises flat bars provided with at least one sharpened edge on one of its long sides. The knife arms are arranged to act as fan blades guiding the air stream with chopped straw exiting from the apparatus housing, by the fact that each knife arm has said at least one edge bevelled in a respective oblique sharpening plane extending substantially throughout the thickness of respective knife arm. A desired spreading direction and spreading width of the chopped straw is obtained by arranging the detachable knife arms with their sharpening planes in different configurations with respect to each other.
Patent FI-883388-A0 (FI)
Inventor: SCHALLY ANDREW V
IPC: C07K1/04
Filed: 1988-07-15
Abstract: The present invention deals with LHRH antagonists which possess improved water solubility and while having the high antagonist potency of the basic peptides, are free of the edematogenic effects. These compounds are highly potent in inhibiting the release of gonadotropins from the pituitary gland in mammals, including humans. The compounds of this invention are represented by the formula X-R1-R2-R3-Ser-Tyr-R6-Leu-Arg-Pro-R10-NH2 wherein X is an acyl group derived from straight or branched chain aliphatic or alicyclic carboxylic acids having from 1 to 7 carbon atoms, or H2N-CO, R1 is D- or L-Pro, D- or L- DELTA 3-Pro, D-Phe, D-Phe(4-H1), D-Ser, D-Thr, D-Ala, D-Nal(1) or D-Nal (2), R2 is D-Phe or D-Phe(4-C1) R3 is D-Trp, D-Phe, D-Pal(3), D-Nal(1) or D-Nal(2), R6 is D-Cit, D-Hci, D-Cit(Q) or D-Hci(Q) and R10 is Gly or D-Ala where Q is lower alkyl of 1-3 carbon atoms and H1 is fluoro, chloro or bromo, and the pharmaceutically acceptable acid addition salts thereof and methods of use pertaining to these compounds.
Patent FI-891537-A0 (FI)
Inventor: SLEGERS JOHN
IPC: B01D61/00
Filed: 1989-03-30
Abstract: An improved method of operating a membrane separation system is provided, which comprises applying a reduced pressure to one side of the or each membrane to thereby cause fluid to be drawn through the or each membrane from the other side thereof. As the method does not utilize fluid under pressure, which has typically been required in prior art procedures, the risk of damage to the membranes is eliminated, or at least minimised.
Patent FI-893372-A0 (FI)
Inventor: DEVIC MICHEL
IPC: D21C3/04
Filed: 1989-07-11
Abstract: Process for manufacturing bleached CTMP pulps comprising a treatment of the lignocellulosic stock with sulphite at a temperature of at least 100 DEG C under saturated steam pressure, and a bleaching operation with the aid of H2O2 in alkaline medium without removal of solid or liquid matter from the pulp from the start of the treatment until the end of the bleaching.
Patent FI-904184-A0 (FI)
Inventor: ALLEN RICHARD C
IPC: A61P17/00
Filed: 1990-08-23
Abstract: This invention relates to N-hydroxy-dibenz[b,e]oxepinalkylamines, N-hydroxy-dibenz[b,e]oxepinalkanoic acid amides and related heterocyclic analogues of the formula <CHEM> where X together with the carbon atoms to which it is attached forms a benzene or thiophene ring; W and Z are independently hydrogen, halogen, loweralkyl, or trifluoromethyl, R<1> is hydrogen, loweralkyl, or acyl; R<2> is hydrogen, loweralkyl, cycloalkyl, arylloweralkyl or acyl; m is 0 or 1 and n is an integer of 0 to 12 and the pharmaceutically acceptable salts thereof. The compounds of this invention exhibit dermatological and analgesic activity.
Patent FI-906090-A0 (FI)
Inventor: MUELLER HORST
IPC: H04J3/16
Filed: 1990-12-11
Abstract: A method for transmitting 1544 or 6312-kbit/s signals via a 2048 or 8448-kbit/s link is not known in the synchronous digital multiplex hierarchy and is to be specified. A 1544-kbit/s signal is inserted in the direction of multiplexing, using a gapped 2048-kHz clock (LT11) into a container C-111 which is completed by means of a path overhead V511 to form a virtual container VC-1111. This is transmitted via a 2048-kbit/s link (L11) with a link container (S-1111) to which a header (OH11) and pointer bytes V111 to V411 are allocated for the transmission. After adding stuffing bytes (FS11), the 1544-kbit/s signal can be fed into a subsystem unit TU-121. In the direction of demultiplexing, stuffing bytes (FS12) must be removed from a subsystem unit TU-122 and pointer bytes V112 to V412 must be inserted with the aid of a gapped 2048-kHz clock (LT12) and a header (OH12) must be inserted with the aid of a 2048-kHz clock (T12) for the transmission via a 2048-kbit/s link (L12). After the transmission, the header (OH12), the pointer bytes V112 to V412 and a path overhead V512 are removed so that the 1544-kbit/s signal can be taken from a container C-112. A 6312-kbit/s signal is transmitted correspondingly. <IMAGE>
Patent FI-913918-A0 (FI)
Inventor: SUH KYUNG W
IPC: D01F9/30
Filed: 1991-08-19
Abstract: Fibrous thermal insulation comprises an intimate blend of A) non-graphitic carbonized fibers having an LOI value greater than 40, a percentage char value greater than 65, and a thermal conductivity less than 1.7 W/(m.<o>K) (1.7 W/m.<o>C)), and B) hollow thermoplastic fibers.
Patent FI-922803-A0 (FI)
Inventor: GLEIM GUENTER
IPC: H02P6/15
Filed: 1992-06-17
Abstract: An electronically commutated motor is controlled by controlling the winding current of the motor. During an operational mode change of the motor, the winding current is first changed to a value in excess of the value needed to maintain a measured motor parameter at a desired level. When the desired level of the parameter is reached the current is changed to the value needed to maintain the parameter at the desired level. In addition, the communication time of the motor is shifted such that the temporal maximum of the magnetic field of the motor coincides with the position of the motor poles which results in attainment of a maximum speed altering force.
Patent FI-932769-A0 (FI)
Inventor: BASSLER KENNETH G
IPC: A61K9/08
Filed: 1993-06-16
Abstract: A pharmaceutical composition of probucol that both enhances bioavailability of the drug and reduces plasma drug level variability in a patient population comprising a therapeutically effective amount of probucol dissolved in a propylene glycol ester of fatty acids wherein the fatty acids are selected from the group consisting of the fatty acids represented by CxH2xO2, wherein x is 4, 6, 8, 10, 12, 14, 16.
Patent FI-933349-A0 (FI)
Inventor: VOLKMANN ROBERT A
IPC: A61P1/00
Filed: 1993-07-26
Abstract: PCT No. PCT/US93/05392 Sec. 371 Date Apr. 27, 1995 Sec. 102(e) Date Apr. 27, 1995 PCT Filed Jun. 10, 1993 PCT Pub. No. WO94/02511 PCT Pub. Date Feb. 3, 1994A polypeptide isolated from the venom of the Agelenopsis aperta spider blocks calcium channels in cells of various organisms and is useful in blocking such calcium channels in cells per se, in the treatment of calcium channel-mediated diseases and conditions, and in the control of invertebrate pests.
Patent FI-942584-A0 (FI)
Inventor: WINDFELD JAN
IPC: H02G3/04
Filed: 1994-06-01
Abstract: A distribution duct includes a plurality of cable shelves for distribution of power cables, i.e. heavy current cables (23), data connections, telephone cables and/or cables (25) from outlet sockets and with a plurality of turnable terminal means (10) provided in connection with at least one of the shelves. In front of the shelf, sliding panels (30) are arranged which can be lifted upwards when the user wishes to have access to the terminal means (10) at this shelf. The connecting means may be a terminal means (10) which can turn about a first pivot while an inner terminal means can optionally turn about a second pivot arranged perpendicular to said first pivot. The turnable terminal means (10) renders it possible to make the distribution duct (20) narrower than previously known for distribution ducts with built-in hidden terminal means. The terminal means is preferably supplied with power through a cable current collector module (50) with a base member with two wings, one wing on each side of the current collector module. Each wing forms at least one bearing or hinge carrying the substantially vertical pivot, about which the terminal means (10) can turn. <IMAGE>
Patent FI-943211-A0 (FI)
Inventor: KLEIN MICHEL H
IPC: C07K14/115
Filed: 1994-07-05
Abstract: Multimeric hybrid genes encoding the corresponding chimeric protein comprise a gene sequence coding for an antigenic region of a protein from a first pathogen linked to a gene sequence coding for an antigenic region of a protein from a second pathogen. The pathogens particularly are parainfluenza virus (PIV) and respiratory syncytial virus (RSV). A single recombinant immunogen is capable of protecting infants and similar susceptible individuals against diseases caused by both PIV and RSV.
Patent FI-943561-A0 (FI)
Inventor: GEACH NEIL
IPC: C07D417/06
Filed: 1994-07-29
Abstract: The invention relates to isoxazole derivatives of formula (I): <CHEM>     wherein:   Ar represents phenyl optionally substituted by from one to three groups and wherein two substituents on adjacent positions of the phenyl ring, together with the two atoms to which they are attached, form a 5- to 7- membered ring which is optionally substituted ;   R represents the hydrogen atom or a group -CO2R<3>; R<1> represents alkyl, haloalkyl or optionally substituted cycloalkyl; R<3> represents alkyl, alkenyl or alkynyl containing up to six carbon atoms which is optionally substituted by one or more halogen atoms; and their use as herbicides.
Patent FI-951384-A0 (FI)
Inventor: MARIS CATHERINE AUGUSTA LOUIS
IPC: C08L/
Filed: 1995-03-23
Abstract: Conveyor belt, obtainable by application of a block copolymer composition, comprising at least an optionally modified block copolymer, containing at least two terminal poly(vinylaromatic) blocks and at least one internal poly(conjugated diene) block, a non-aromatic plasticizing oil, and a terminal block compatible resin on at least one side of a fabric having from 5 to 25 threads per cm and process for the manufacture of it, while the threads in said fabric have a thickness in the range of from 2 mu  to 300 mu .
Patent FI-951868-A0 (FI)
Inventor: URIACH-MARSAL JUAN
IPC: A23L27/24
Filed: 1995-04-19
Abstract: Thaumatin II or thaumatin I can be obtained through the expression, not of their natural genes, but of artificial, synthetic and substantially optimized genes following specific rules. Preferably, this expression is carried out in filamentous fungi, especially GRAS fungi and particularly the species Penicillium roquefortii, Aspergillus niger and the awamori variant of Aspergillus niger. Preparing substantially optimized artificial genes for filamentous fungi, performed here for the first time in the case of thaumatin, allows for high protein expression, making the process useful for industrial production of this valuable sweetener. Thaumatins may be obtained extracellularly by using a plasmid with a secretion signal, and also intracellularly. The latter method can be used in animal feed without prior separation from the fungal mycelium.
Patent FI-953731-A0 (FI)
Inventor: SANDERSON THOMAS
IPC: C12N5/10
Filed: 1995-08-04
Abstract: A process for growing a PRRSV in a tissue culture which is susceptible to infection and replication of PRRSV to an amount sufficient to protect animals against PRRS or be used in diagnosing PRRS or identifying the molecular structure of PRRSV for development of recombinant products, comprising inoculating the PRRSV onto the tissue culture and harvesting the replicated PRRSV.
Patent FI-961093-A0 (FI)
Inventor: GERGELY THOMAS
IPC: A61K9/16
Filed: 1996-03-08
Abstract: PCT No. PCT/EP94/03018 Sec. 371 Date Mar. 26, 1996 Sec. 102(e) Date Mar. 26, 1996 PCT Filed Sep. 9, 1994 PCT Pub. No. WO95/07070 PCT Pub. Date Mar. 16, 1995An effervescent granulated material for a pharmaceutical preparation contains calcium carbonate and citric acid. From 5-20 parts by weight of the total acid provided for the reaction with the calcium carbonate is replaced by at least one of malic acid, gluconic acid, lactic acid, and their salts. Citric acid and calcium carbonate are granulated with a partial reaction, and in each case at least part of the compound partially replacing the citric acid is granulated in solid, powdered form together with the citric acid and the calcium carbonate and/or dissolved in a granulation liquid or buffer solution.
Patent FI-974580-A0 (FI)
Inventor: HIPPELAEINEN LEO
IPC: H04L12/56
Filed: 1997-12-19
Abstract: The invention relates to a method for transmitting data in a telecommunication system that comprises at least one packet-switched transmission network, in which data is transmitted in data packets of a standard length, the number of such standard lengths being determined in advance. To transfer information in as compact form as possible, a unique length code (L) is maintained for each standard length, and to each packet is added a length code (L) corresponding to the header of the packet to be transferred to indicate the length (3) of the packet. The invention further relates to a telecommunication system in which the method of the invention can be utilized.
Patent AP-9901559-A0 (AP)
Title: Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
Inventor: WU YONG-JIN
IPC: C07H17/08
Filed: 1999-06-03
Abstract: The invention relates to compounds of the formula and to pharmaceutically acceptable salts thereof, wherein r7, r1, r3 and r2 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula 1, methods of using said compounds of formula 1 in the treatment of infections, and methods of preparing said compounds of formula 1.
Patent IL-68479-A0 (IL)
Title: Norscopolamine derivatives,their preparation and their use for preparing pharmaceutically active compounds
IPC: A61K31/46
Filed: 1983-04-25
Abstract: The invention relates to novel N-alkylnorscopines wherein the alkyl group may have 2 to 10 carbon atoms, which are useful in the preparation of valuable pharmaceutical compositions. These compounds may be prepared from the corresponding N-alkylnorscopolamines by hydrogenolysis with complex hydrides, which reaction is preferably carried out with sodium borohydride in ethanol at ambient temperature.
Patent IL-70781-A0 (IL)
Title: Plant protection agents in the form of mixed dispersions
IPC: A01N47/30
Filed: 1984-01-25
Abstract: The aqueous mixed dispersions, according to the invention, of pesticides, which contain an active compound concentrate, based on (C1-C12)-alkyl phthalates as the solvent, of one or more active compounds melting below 70 DEG  C., in combination with an aqueous suspension concentrate of one or more active compounds melting above 70 DEG  C., possess surprisingly high stability on storage.
Patent IL-75597-A0 (IL)
Title: Synergistic mixtures of interferons and tumour necrosis factor
IPC: A61K38/16
Filed: 1985-06-21
Abstract: Ternary compositions of an interferon of the alpha and/or beta type with an interferon of the gamma type and tumor necrosis factor having a surprising and unexpected synergistic anti-proliferative effect on neoplastic cells when compared to the activity of the individual components of this invention, said compositions being useful in the treatment of neoplasia in animals including humans.
Patent IL-76535-A0 (IL)
Title: Furo(3,2-c)pyridine derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61K31/435
Filed: 1985-09-29
Abstract: Compounds of general formula (I)    <IMAGE>  (I)  wherein R1 represents a phenyl, halophenyl, methylphenyl, ethylphenyl, methoxyphenyl, trifluoromethylphenyl or naphthyl group, R2 represents hydrogen or a methyl or phenyl group, and R3 represents hydrogen or a benzyl group, except compounds in which R1 is a phenyl or 4-fluorophenyl group, R2 is hydrogen and R3 is hydrogen or a benzyl group, and their pharmaceutically acceptable acid addition salts have useful anti-depressant and anti-ischaemic properties.
Patent IL-79292-A0 (IL)
Title: Production of small spherical polymer particles
IPC: A61K9/16
Filed: 1986-06-30
Abstract: The invention relates to a method of producing small spherical polymer particles from systems containing two liquid phases, the one phase of which contains one or more dissolved substances and is dispersed in the form of small droplets in the other phase to form an emulsion, whereafter the droplets are converted to a solid form. According to the invention the liquid phases used are two mutually immiscible aqueous phases.
Patent IL-93734-A0 (IL)
Title: Dna probe for lactobacillus delebrueckii
IPC: C07H21/04
Filed: 1990-03-13
Abstract: The DNA probe comprises a DNA fragment capable of hybridisation to chromosomal DNA of strains of the L.delbrueckii species. This DNA fragment comprises an EcoRI fragment of chromosomal DNA from a strain of the L.delbrueckii species.